Skip to main content
Premium Trial:

Request an Annual Quote

Still Awaiting Approval by Chinese Agencies, BGI-Shenzhen Extends Offer for Complete Genomics

NEW YORK (GenomeWeb News) – BGI-Shenzhen said late on Wednesday that it has again extended its cash tender offer for Complete Genomics.

The offer is now set to expire midnight EST on Feb. 22. The extension is to allow China's Ministry of Commerce time to approve the deal and China's State Administration of Foreign Exchange to register the transaction, BGI said. It also noted the upcoming Chinese New Year holiday in China, which is set to begin Feb. 9 and end Feb. 15.

The $118 million deal had been set to expire midnight on Feb. 6.

The depositary for the offer has indicated that as of the close of business on Wednesday, about 30,967,711 shares, or 87 percent, of Complete Genomics' common stock have been tendered and not withdrawn.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.